Protecting Firefighters from Carcinogenic Exposure: Emerging Tools for PAH Detection and Decontamination.

Biosensors (Basel)

Biologically Inspired Sensors and Actuators Laboratory (BioSA), Department of EECS, Lassonde School of Engineering, York University, 4700 Keele Street, Toronto, ON M3J 1P3, Canada.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Polycyclic aromatic hydrocarbons (PAHs) are increasingly recognized as a major contributor to the occupational cancer risk among firefighters. In response, the National Fire Protection Association (NFPA) and other regulatory bodies have recommended rigorous decontamination protocols to minimize PAH exposure. Despite these efforts, a critical gap persists: the absence of real-time, field-deployable devices capable of detecting these invisible and toxic compounds during firefighting operations or within fire stations. Additionally, the lack of effective and optimized methods for the removal of these hazardous substances from the immediate environments of firefighters continues to pose a serious occupational health challenge. Although numerous studies have investigated PAH detection in environmental contexts, current technologies are still largely confined to laboratory settings and are unsuitable for field use. This review critically examines recent advances in PAH decontamination strategies for firefighting and explores alternative sensing solutions. We evaluate both conventional analytical methods, such as gas chromatography, high-performance liquid chromatography, and mass spectrometry, and emerging portable PAH detection technologies. By highlighting the limitations of existing systems and presenting novel sensing approaches, this paper aims to catalyze innovation in sensor development. Our ultimate goal is to inspire the creation of robust, field-deployable tools that enhance decontamination practices and significantly improve the health and safety of firefighters by reducing their long-term risks of cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12384513PMC
http://dx.doi.org/10.3390/bios15080547DOI Listing

Publication Analysis

Top Keywords

pah detection
12
pah
5
protecting firefighters
4
firefighters carcinogenic
4
carcinogenic exposure
4
exposure emerging
4
emerging tools
4
tools pah
4
decontamination
4
detection decontamination
4

Similar Publications

Polycyclic aromatic hydrocarbons (PAHs), carcinogenic persistent organic compounds, require ultrasensitive detection for health risk assessment of tobacco products. While traditional cigarette smoke contains FDA-monitored PAHs (e.g.

View Article and Find Full Text PDF

Objective: To explore the method of active monitoring of adverse drug events (ADEs) in patients with a rare disease: pulmonary arterial hypertension (PAH).

Methods: First, initial trigger items were extracted and organized through literature-based evidence and drug inserts. Then, the trigger items were refined using expert consultation based on a Delphi method.

View Article and Find Full Text PDF

Background: Pulmonary arterial hypertension (PAH), a serious disease, is characterized by various degrees of pulmonary vascular remodeling, inflammation, and increased vascular resistance, leading to fatalities in patients with severe conditions. However, the molecular mechanisms underlying the pathogenesis of PAH remain incompletely understood.

Methods: RNA sequencing (RNA-seq), 4D label-free proteomics, and phosphoproteomics were employed to detect the levels of mRNA, proteins, and phosphorylation modification in the lung tissues of PAH patients, compared to those in the control group.

View Article and Find Full Text PDF

Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine.

Ther Adv Respir Dis

August 2025

Department of Cell Biology and Anatomy, and Physiology, New York Medical College, 15 Dana Road, BSB 131A, Valhalla, NY 10595, USA Department of Physiology, New York Medical College, Valhalla, NY, USA.

Pulmonary arterial hypertension (PAH) is a rare but fatal disease characterized by progressive vascular remodeling, which results in increased pulmonary vascular resistance and elevated pulmonary arterial pressure. These changes are detrimental to the right ventricle (RV). If not treated, it can eventually lead to maladaptive RV structural changes, right heart failure, and death.

View Article and Find Full Text PDF

Polycyclic aromatic hydrocarbons (PAHs) are widespread environmental contaminants that pose health risks to humans. Toxicity testing approaches of PAHs have evolved from traditional rodent models to New Approach Methodologies (NAMs), such as high-throughput screening in zebrafish, enabling rapid evaluation of chemical hazards. However, translating toxicity findings from laboratory systems to humans remains difficult due to complexity and species-specific differences.

View Article and Find Full Text PDF